The North America Opioids Market would witness market growth of 3.2% CAGR during the forecast period (2021-2027).
Physician anesthesiologists, who specialize in anesthesia, pain management, and critical care medicine, have significant training and experience administering both opioid and non-opioid pain drugs. If a patient requires assistance with pain management, a medical anesthesiologist can work with them to ensure that their pain is controlled while reducing side effects and the danger of addiction.
Opioids function by binding to opioid receptors in the brain and other parts of the body, inhibiting pain signals from the body from reaching the brain. Many individuals find relief after taking the medicine because it masks pain.
Doctors at the Valley Medical Pain Clinic in Minneapolis believe that if opioids are administered in the appropriate dose and according to instructions, they can benefit patients with severe and chronic pain. Patients are at risk of developing an opioid addiction if they use opioids for a long time to address long-term pain. This is why opioids should only be used under the guidance of a doctor.
The demand for opioids is growing substantially in the United Stated, owing to the rising frequency of chronic diseases and the widespread use of opioids as a pain reliever and for illicit purposes. The United States is concentrating its efforts on branded opioid manufacturers looking to launch new medications in order to comply with updated regulatory rules. Furthermore, the United States has dominated the pain management field thanks to government backing for continuous clinical research.
Pfizer, Janssen Pharmaceuticals, Purdue Pharmaceuticals L.P., Assertio Therapeutics, and other North American corporations have all contributed to the country's impressive results. Purdue was the first business to provide opioids with abuse-deterrent formulations qualities, due to the creation of innovative formulations and abuse deterrence research.
The US market dominated the North America Opioids Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1,545 million by 2027. The Canada market is experiencing a CAGR of 5.5% during (2021 - 2027). Additionally, The Mexico market would exhibit a CAGR of 4.6% during (2021 - 2027).
Based on Application, the market is segmented into Pain Management, Cough Treatment and Diarrhea Treatment. Based on Product Type, the market is segmented into Methadone, Oxycodone, Hydrocodone, Fentanyl, Codeine, Morphine and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Opioids Market is Estimated to reach $5.4 Billion by 2027, at a CAGR of 3.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.
By Application
By Product Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
